CHV Capital

CHV Capital operates as a venture capital firm, dedicating its investments to the development of transformative medical technologies. The firm targets innovations designed to address critical global unmet needs, focusing on solutions that offer significant advancements in healthcare. Their strategic approach involves identifying and backing early-stage opportunities within the medical technology sector.

Established in 2007, CHV Capital emerged from an understanding of the market's demand for value creation in businesses solving specific clinical or market needs. The current fund was established by Kyle Salyers, building upon the original premise of identifying and nurturing nascent ventures. This foundation allows CHV Capital to provide strategic support to promising companies.

CHV Capital primarily serves early-stage medical technology companies seeking both capital and strategic guidance to bring their innovations to market. The firm's long-term vision centers on fostering the growth of these enterprises, ultimately aiming to drive meaningful progress in healthcare through advanced technologies. Their objective is to support the creation of valuable solutions that fulfill essential demands across the global health landscape.